News & Updates

Stopping TDF prophylaxis immediately postpartum feasible in highly viraemic CHB mothers
Stopping TDF prophylaxis immediately postpartum feasible in highly viraemic CHB mothers
19 Mar 2024 byChristina Lau

In highly viraemic pregnant women with chronic hepatitis B (CHB), stopping peripartum prophylaxis (PP) with tenofovir disoproxil fumarate (TDF) immediately after delivery does not increase the risk of relapse or retreatment vs TDF cessation at ≥4 weeks postpartum. Early withdrawal of PP-TDF, combined with standard neonatal immunization schemes, is 100 percent effective in preventing mother-to-child transmission (MTCT).

Stopping TDF prophylaxis immediately postpartum feasible in highly viraemic CHB mothers
19 Mar 2024
Certain factors predict postnatal depression after C-section
Certain factors predict postnatal depression after C-section
13 Mar 2024
Hysterectomy for low-risk cervical cancer: Less is more?
Hysterectomy for low-risk cervical cancer: Less is more?
05 Mar 2024 byChristina Lau

In patients with low-risk cervical cancer, simple hysterectomy has demonstrated noninferior pelvic recurrence rate at 3 years and lower rates of surgery-related urologic adverse events (AEs) vs radical hysterectomy in the phase III, randomized, noninferiority CX.5 SHAPE trial.

Hysterectomy for low-risk cervical cancer: Less is more?
05 Mar 2024